Skip to main content
. 2022 Oct 24;23(21):12784. doi: 10.3390/ijms232112784

Figure 3.

Figure 3

Gene set variation analysis (GSVA) of the selected PRGs with clinical value between different pathologic stages in LIHC and other digestive system cancers. (A) Original GSVA score between tumor and paracancerous tissues. (B) GSVA-altered pathways in different cancer types from digestive system. (C) GSVA trend analysis of 61 polarity-related genes across digestive system cancers. (D) Detailed trend analysis in LIHC cohort showed difference between pathological stages. *, p < 0.05; #, FDR < 0.05.